imidaprilat has been researched along with Aortic Aneurysm, Abdominal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, D; Li, ZL; Miyazaki, M; Otsuki, Y; Takai, S; Yamamoto, D | 1 |
| Akashi, H; Aoki, H; Aoyagi, S; Furusho, A; Hiromatsu, S; Imaizumi, T; Nishihara, M; Ohno, S; Shintani, Y | 1 |
2 other study(ies) available for imidaprilat and Aortic Aneurysm, Abdominal
| Article | Year |
|---|---|
Significance of matrix metalloproteinase-9 inhibition by imidapril for prevention of abdominal aortic aneurysms in angiotensin II type 1 receptor-knockout mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Gene Knockout Techniques; Imidazolidines; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Elastase; Receptor, Angiotensin, Type 1; Ultrasonography | 2013 |
Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Aorta; Aortic Aneurysm, Abdominal; Cytokines; Endothelial Cells; Hepatocyte Growth Factor; Humans; Imidazolidines; Indoles; Interleukin-10; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2011 |